Select a State

Global health R&D delivers for Pennsylvania

US government investment in global health R&D has delivered

$352.8 million
to Pennsylvania research institutions
4,300+ new jobs
for Pennsylvania
4486

Neglected diseases in Pennsylvania

Chikungunya cases
111
Dengue cases
133
HIV diagnoses
12669
Malaria cases
448
Tuberculosis cases
2150
West Nile cases
178
Zika cases
52

Pennsylvania

--

Pennsylvania's top USG-funded global health R&D institutions

Magee-Womens Research Institute & Foundation
$ 107.3 million
University of Pennsylvania
$ 95.2 million
University of Pittsburgh
$ 69.2 million
Pennsylvania State University
$ 24.4 million
Drexel University
$ 20.4 million
Wistar Institute
$ 18.5 million
Thomas Jefferson University
$ 5.8 million
Particles Sciences
$ 3.4 million
Fox Chase Cancer Center/Institute for Cancer Research Philadelphia
$ 2.5 million
Children's Hospital of Philadelphia
$ 2.3 million

Pennsylvania industry in global health R&D

Actuated Medical
Location(s):
Bellafonte
AstraZeneca
Location(s):
Philadelphia
Bayer
Location(s):
Pittsburgh
Charles River Laboratories
Location(s):
Horsham, King of Prusssia, Malvern
Fox Chase Chemical Diversity Center
Location(s):
Doylestown
GSK
Location(s):
Philadelphia, Upper Merion, Upper Providence
Hydas World Health
Location(s):
Hummelstown
Immunotope
Location(s):
Doylestown
Inovio Pharmaceuticals
Location(s):
Plymouth Meeting
Integral Molecular
Location(s):
Philadelphia
item[company]
Location(s):
Horsham, Malvern, Spring House
item[company]
Location(s):
Woburn
item[company]
Location(s):
Philadelphia
item[company]
Location(s):
Wynnewood
item[company]
Location(s):
Philadelphia
item[company]
Location(s):
Pittsburgh
item[company]
Location(s):
Upper Gwynedd, West Point
item[company]
Location(s):
Sinking Spring
item[company]
Location(s):
Philadelphia
item[company]
Location(s):
Malvern
item[company]
Location(s):
Malvern
item[company]
Location(s):
Philadelphia

Pennsylvania's top areas of global health R&D by USG funding

55.7%
HIV/AIDS
12.1%
Malaria
10.1%
Tuberculosis
3.5%
Diarrheal diseases
12.7%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Trachoma
5.9%
Other
Bacteria pneumonia & meningitis
Ebola/viral hemorrhagic fevers
Non-allocable
Salmonella infections

Global health R&D at work in Pennsylvania

Once HIV therapy is working, HIV can lie dormant in immune cells at low levels. It is critical to determine if this latent HIV reservoir, often containing damaged HIV, could create more virus and cause relapse if treatment is stopped. Now researchers at the University of Pittsburgh have created a test to detect this “hidden” HIV. The test is faster, easier on patients, less labor-intensive, less expensive, and more sensitive than the current gold-standard test.

Footnotes